Follicular Lymphoma — Trials

Follicular Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

775 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 216
Recruiting: 107
Ph III recruiting: 10
Growth YoY: −8.6%
Industry share: 29%
Top sponsor: City of Hope Medical Center
Termination share: 39.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (149)

clinicaltrialsPublishedShowing 301–306 of 306 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01177371	High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma	completed	Phase 2	13	Case Comprehensive Cancer CenterOTHER	1	Aug 9, 2010	clinicaltrials
NCT00859001	Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) Study in Patients With Follicular Grade I-II Lymphoma After 4 Cycles of Fludarabine-Mitoxantrone-Rituximab (FMR) Therapy(FM+R-Z)	completed	Phase 2	55	University of Bologna